The α1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats

Dennis D. Rasmussen, Laura L. Alexander, Murray A. Raskind, Janice C. Froehlich

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background: Preliminary evidence suggest that noradrenergic signaling may play a role in mediating alcohol drinking behavior in both humans and rats. Accordingly, we tested the hypothesis that blockade of α1- adrenergic receptors will suppress alcohol drinking in rats selectively bred for alcohol preference (P line). Methods: Adult male P rats were given 24-hour access to food and water and scheduled access to a 15% (v/v) alcohol solution for 2 hours daily. Rats were injected IP with the α1-adrenergic receptor antagonist, prazosin (0, 0.5, 1.0, 1.5, or 2.0 mg/kg body weight), once a day at 15 minutes prior to onset of the daily 2-hour 2-bottle choice, alcohol versus water, access period for 2 consecutive days and then 3 weeks later for 5 consecutive days. Results: Prazosin significantly reduced (p < 0.01) alcohol intake during the initial 2 daily administrations, and this reduction of alcohol intake was maintained for 5 consecutive days by daily prazosin treatment in the subsequent more prolonged trial (p < 0.05). The prazosin-induced reduction of alcohol intake was not dependent upon drug-induced motor impairment since increases in water drinking (p < 0.05) were exhibited during the 2-hour access periods during both 2- and 5-day prazosin treatment. Conclusions: The results indicate that the noradrenergic system plays a role in mediating alcohol drinking in rats of the P line and suggest that prazosin - a safe, well-characterized, and well-tolerated drug - may be an effective pharmacotherapeutic agent for the treatment of alcohol use disorders.

Original languageEnglish (US)
Pages (from-to)264-272
Number of pages9
JournalAlcoholism: Clinical and Experimental Research
Volume33
Issue number2
DOIs
StatePublished - Feb 1 2009

Fingerprint

Adrenergic Antagonists
Prazosin
Alcohol Drinking
Rats
Alcohols
Drinking Behavior
Water
Drinking Water
Pharmaceutical Preparations
Adrenergic Receptors
Bottles
Body Weight
Food

Keywords

  • Alcohol
  • Alcohol-preferring
  • Noradrenergic
  • P rats
  • Prazosin

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Toxicology
  • Medicine(all)

Cite this

The α1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats. / Rasmussen, Dennis D.; Alexander, Laura L.; Raskind, Murray A.; Froehlich, Janice C.

In: Alcoholism: Clinical and Experimental Research, Vol. 33, No. 2, 01.02.2009, p. 264-272.

Research output: Contribution to journalArticle

@article{39ee7b39e46f4abb8be5853b19ab526e,
title = "The α1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats",
abstract = "Background: Preliminary evidence suggest that noradrenergic signaling may play a role in mediating alcohol drinking behavior in both humans and rats. Accordingly, we tested the hypothesis that blockade of α1- adrenergic receptors will suppress alcohol drinking in rats selectively bred for alcohol preference (P line). Methods: Adult male P rats were given 24-hour access to food and water and scheduled access to a 15{\%} (v/v) alcohol solution for 2 hours daily. Rats were injected IP with the α1-adrenergic receptor antagonist, prazosin (0, 0.5, 1.0, 1.5, or 2.0 mg/kg body weight), once a day at 15 minutes prior to onset of the daily 2-hour 2-bottle choice, alcohol versus water, access period for 2 consecutive days and then 3 weeks later for 5 consecutive days. Results: Prazosin significantly reduced (p < 0.01) alcohol intake during the initial 2 daily administrations, and this reduction of alcohol intake was maintained for 5 consecutive days by daily prazosin treatment in the subsequent more prolonged trial (p < 0.05). The prazosin-induced reduction of alcohol intake was not dependent upon drug-induced motor impairment since increases in water drinking (p < 0.05) were exhibited during the 2-hour access periods during both 2- and 5-day prazosin treatment. Conclusions: The results indicate that the noradrenergic system plays a role in mediating alcohol drinking in rats of the P line and suggest that prazosin - a safe, well-characterized, and well-tolerated drug - may be an effective pharmacotherapeutic agent for the treatment of alcohol use disorders.",
keywords = "Alcohol, Alcohol-preferring, Noradrenergic, P rats, Prazosin",
author = "Rasmussen, {Dennis D.} and Alexander, {Laura L.} and Raskind, {Murray A.} and Froehlich, {Janice C.}",
year = "2009",
month = "2",
day = "1",
doi = "10.1111/j.1530-0277.2008.00829.x",
language = "English (US)",
volume = "33",
pages = "264--272",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - The α1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats

AU - Rasmussen, Dennis D.

AU - Alexander, Laura L.

AU - Raskind, Murray A.

AU - Froehlich, Janice C.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Background: Preliminary evidence suggest that noradrenergic signaling may play a role in mediating alcohol drinking behavior in both humans and rats. Accordingly, we tested the hypothesis that blockade of α1- adrenergic receptors will suppress alcohol drinking in rats selectively bred for alcohol preference (P line). Methods: Adult male P rats were given 24-hour access to food and water and scheduled access to a 15% (v/v) alcohol solution for 2 hours daily. Rats were injected IP with the α1-adrenergic receptor antagonist, prazosin (0, 0.5, 1.0, 1.5, or 2.0 mg/kg body weight), once a day at 15 minutes prior to onset of the daily 2-hour 2-bottle choice, alcohol versus water, access period for 2 consecutive days and then 3 weeks later for 5 consecutive days. Results: Prazosin significantly reduced (p < 0.01) alcohol intake during the initial 2 daily administrations, and this reduction of alcohol intake was maintained for 5 consecutive days by daily prazosin treatment in the subsequent more prolonged trial (p < 0.05). The prazosin-induced reduction of alcohol intake was not dependent upon drug-induced motor impairment since increases in water drinking (p < 0.05) were exhibited during the 2-hour access periods during both 2- and 5-day prazosin treatment. Conclusions: The results indicate that the noradrenergic system plays a role in mediating alcohol drinking in rats of the P line and suggest that prazosin - a safe, well-characterized, and well-tolerated drug - may be an effective pharmacotherapeutic agent for the treatment of alcohol use disorders.

AB - Background: Preliminary evidence suggest that noradrenergic signaling may play a role in mediating alcohol drinking behavior in both humans and rats. Accordingly, we tested the hypothesis that blockade of α1- adrenergic receptors will suppress alcohol drinking in rats selectively bred for alcohol preference (P line). Methods: Adult male P rats were given 24-hour access to food and water and scheduled access to a 15% (v/v) alcohol solution for 2 hours daily. Rats were injected IP with the α1-adrenergic receptor antagonist, prazosin (0, 0.5, 1.0, 1.5, or 2.0 mg/kg body weight), once a day at 15 minutes prior to onset of the daily 2-hour 2-bottle choice, alcohol versus water, access period for 2 consecutive days and then 3 weeks later for 5 consecutive days. Results: Prazosin significantly reduced (p < 0.01) alcohol intake during the initial 2 daily administrations, and this reduction of alcohol intake was maintained for 5 consecutive days by daily prazosin treatment in the subsequent more prolonged trial (p < 0.05). The prazosin-induced reduction of alcohol intake was not dependent upon drug-induced motor impairment since increases in water drinking (p < 0.05) were exhibited during the 2-hour access periods during both 2- and 5-day prazosin treatment. Conclusions: The results indicate that the noradrenergic system plays a role in mediating alcohol drinking in rats of the P line and suggest that prazosin - a safe, well-characterized, and well-tolerated drug - may be an effective pharmacotherapeutic agent for the treatment of alcohol use disorders.

KW - Alcohol

KW - Alcohol-preferring

KW - Noradrenergic

KW - P rats

KW - Prazosin

UR - http://www.scopus.com/inward/record.url?scp=58849140930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849140930&partnerID=8YFLogxK

U2 - 10.1111/j.1530-0277.2008.00829.x

DO - 10.1111/j.1530-0277.2008.00829.x

M3 - Article

C2 - 19032582

AN - SCOPUS:58849140930

VL - 33

SP - 264

EP - 272

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 2

ER -